
EXPERT REACTION: Johnson & Johnson pauses COVID-19 vaccine trial
Opinion piece/editorial: This work is based on the opinions of the author(s)/institution.
US pharmaceutical company Johnson & Johnson has confirmed it has temporarily paused its COVID-19 vaccine clinical trials due to an unexplained illness in a study participant. While the company did not elaborate on the illness, the pause follows a similar action by British-Swedish pharmaceutical company AstraZeneca, who paused their trial in September, however their trials have since resumed. Below Australian experts respond.
Organisation/s: The Kirby Institute for Infection and Immunity in Society, The University of New South Wales, La Trobe University, Murdoch University, The University of Queensland, Australian Catholic University, Johnson & Johnson
Attachments:
Note: Not all attachments are visible to the general public
News for:
Australia
International
NSW
VIC
QLD
WA
Media contact details for this story are only visible to registered journalists.
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.
Jeremy Nicholson is Pro-Vice Chancellor of Health Sciences at Murdoch University and Director of the Australian National Phenome Centre